i always forget religious posts like this are dead serious because starting out with the phrase “i knew my flesh was evil” is so incredibly funny to me
people who don’t watch horror movies are SO confident that they know everything there is to know about the genre. like it’s okay to not know things. it’s okay if you don’t like friday the 13th or whatever. i promise you don’t need to make an ass out of yourself on the internet about it
horror is an incredibly diverse genre, because there is potential horror in everything. it’s in nature, it’s in architecture and technology, it’s in human relationships, it’s in folklore, the past, the future, the mundane. there are horror movies from all over the world. it is straight up anti-intellectual to pretend that the handful of B slashers you’ve vaguely heard about comprise the totality of what horror has to offer. If you’re just not interested in horror, or if you dislike certain subgenres of horror, then that’s fine, you’re not obligated to like anything at all. but smugly announcing that you don’t like horror because you dislike a handful of VERY specific non-universal tropes is just as stupid as saying that you hate comedy because you don’t like adam sandler movies.
Global Experts Establish New Name for PCOS to Reflect Multisystem Disease
Polycystic ovary syndrome (PCOS), a condition affecting more than 170 million people worldwide, has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a landmark global consensus study published today in The Lancet.
The new name recognizes that the condition is not a primarily gynecological disorder, but is instead a complex, multisystem condition involving endocrine, metabolic, reproductive, dermatological and psychological health. Additionally, the recategorizing will include updates to clinical guidelines, medical education and international disease classification systems, ensuring the new terminology is adopted consistently worldwide.
“Renaming this condition is more than semantics; it’s about finally recognizing the full reality of what patients experience,” said Melanie Cree, MD, PhD, a pediatric endocrinologist at the University of Colorado Anschutz and one of only two U.S.-based pediatric endeocrinologists involved in this international effort. “For too long, the narrow definition of PCOS has overlooked its metabolic and hormonal complexity, leaving many patients undiagnosed or misunderstood.”
For decades, the term “polycystic ovary syndrome” has been widely recognized as inaccurate and limiting. Despite its name, many patients do not have ovarian cysts, which has obscured the condition’s broader health implications.
This mischaracterization has had tangible consequences: delayed diagnoses, fragmented care, stigma and missed opportunities for early intervention in metabolic and cardiovascular risks. The newly adopted name, PMOS, directly addresses these shortcomings by:
Reflecting the condition’s hormonal (polyendocrine) complexity
Acknowledging its strong metabolic and cardiometabolic affects
Continuing to emphasize the role of ovaries without overemphasizing reproductive aspects
“Language matters in medicine,” said Cree. “The previous name often led to misconceptions and stigma, particularly around fertility. This change helps shift the conversation toward overall health rather than a single aspect of the condition.”
Experts say this change is far more than cosmetic; it is expected to reshape how the condition is diagnosed, treated and researched globally. By moving beyond a narrow reproductive framing, PMOS:
Promotes earlier and more accurate diagnosis
Supports more holistic, patient-centered care
Reduces stigma associated with fertility-focused terminology
Expands research into metabolic and systemic impacts
As implementation begins, the new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), is expected to usher in a new era of awareness, research and improved outcomes for millions of patients around the world. This milestone reflects a growing global recognition: accurately naming a condition is foundational to understanding it and to delivering the care patients deserve.
“What makes this effort especially powerful is that it reflects the voices of thousands of patients and clinicians from around the world,” said Cree. “This renaming sets the foundation for meaningful change, from medical education to clinical guidelines to public awareness, and ultimately, better outcomes for patient care.”
>Only two workshop participants were unsupportive of a name change, citing evolving science related to the genetic component of PCOS, the potential for a male phenotype, and concerns around rebranding and marketing.
so now we are stuck with the new name that has "ovarian" in it even though we already know close male relatives of PCOS/PMOS havers can have similar metabolic/endocrine problems and research into them/effects on their reproductive systems/genetic components could tell us more about the nature of the syndrome. feels like even when the doctors want to "right the wrongs of years of systemic sexism" they still are caught in the underlying belief about the totality of sexual dimorphism. (idk i personally wouldve wanted more research on genetics and metabolism in families to have clearer image on etiology and how it interacts with sexually dimorphic anatomical traits before giving a new name. but im not a doctor)
The majority of people who report seeing ghosts are women. So why don’t you believe women? What other things do women report experiencing in great numbers do you think they’re lying about?
discoholicmusic
origamiaround
jimmyeatworldofficial
stormborns
vaporwave
